Controlled trial of prednisone and azathioprine in active chronic hepatitis.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000906:Antibodies; D000974:Antibodies, Antinuclear; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D001663:Bilirubin / Q000097:blood; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004932:Esophageal and Gastric Varices / Q000150:complications; D006505:Hepatitis / Q000150:complications / Q000188:drug therapy*; D006511:Hepatitis B Antigens; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology; D008875:Middle Aged; D008930:Mitochondria, Liver / Q000276:immunology; D009130:Muscle, Smooth / Q000276:immunology; D010919:Placebos; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D012709:Serum Albumin; D005719:gamma-Globulins
D000906:Antibodies; D000974:Antibodies, Antinuclear; D006511:Hepatitis B Antigens; D010919:Placebos; D012709:Serum Albumin; D005719:gamma-Globulins; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001379:Azathioprine; D001663:Bilirubin; D011241:Prednisone